Disease on EC 3.4.21.84 - limulus clotting factor C
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Adenocarcinoma
Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features.
Adenocarcinoma
Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.
Adenocarcinoma
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Adenocarcinoma
Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Alveolar Bone Loss
Effect of VEGFC on lymph flow and inflammation-induced alveolar bone loss.
Arthritis
Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice.
Arthritis, Psoriatic
[Psoriasis arthropathica and seronegative rheumatoid arthritis--differential diagnostic considerations]
Arthritis, Rheumatoid
Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
Arthritis, Rheumatoid
VEGF-C Gene Polymorphisms Increase Susceptibility to Rheumatoid Arthritis.
Arthritis, Rheumatoid
[Psoriasis arthropathica and seronegative rheumatoid arthritis--differential diagnostic considerations]
Azoospermia
A common 1.6 mb Y-chromosomal inversion predisposes to subsequent deletions and severe spermatogenic failure in humans.
Azoospermia
A family of human Y chromosomes has dispersed throughout northern Eurasia despite a 1.8-Mb deletion in the azoospermia factor c region.
Azoospermia
A frequent Y chromosome b2/b3 subdeletion shows strong association with male infertility in Han-Chinese population.
Azoospermia
A novel partial deletion of the Y chromosome azoospermia factor c region is caused by non-homologous recombination between palindromes and may be associated with increased sperm counts.
Azoospermia
Additional genomic duplications in AZFc underlie the b2/b3 deletion-associated risk of spermatogenic impairment in Han Chinese population.
Azoospermia
An infertile patient with Y chromosome b1/b3 deletion presenting with congenital bilateral absence of the vas deferens with normal spermatogenesis.
Azoospermia
Analysis of partial azoospermia factor c deletion and DAZ copy number in azoospermia and severe oligozoospermia.
Azoospermia
Characterization of Deletions in the DYS385 Flanking Region and Null Alleles Associated with AZFc Microdeletions in Koreans.
Azoospermia
DAZ1/DAZ2 cluster deletion mediated by gr/gr recombination per se may not be sufficient for spermatogenesis impairment: a study of Chinese normozoospermic men.
Azoospermia
Decreased fertilization rate and embryo quality after ICSI in oligozoospermic men with microdeletions in the azoospermia factor c region of the Y chromosome.
Azoospermia
Detection of Partial Deletions of Y-chromosome AZFc in Infertile Men Using the Multiplex Ligation-dependent Probe Amplification Assay.
Azoospermia
Development of a multiplex quantitative fluorescent PCR assay for identification of rearrangements in the AZFb and AZFc regions.
Azoospermia
Diagnosis of the gr/gr Y chromosome microdeletion does not help in the treatment of infertile American men.
Azoospermia
Differential effect of specific gr/gr deletion subtypes on spermatogenesis in the Chinese Han population.
Azoospermia
Dynamic nature of the proximal AZFc region of the human Y chromosome: multiple independent deletion and duplication events revealed by microsatellite analysis.
Azoospermia
Early detection of Y chromosome microdeletions in infertile men is helpful to guide clinical reproductive treatments in southwest of China.
Azoospermia
Gene copy number alterations in the azoospermia-associated AZFc region and their effect on spermatogenic impairment.
Azoospermia
Gene copy number reduction in the azoospermia factor c (AZFc) region and its effect on total motile sperm count.
Azoospermia
Genetic abnormalities among severely oligospermic men who are candidates for intracytoplasmic sperm injection.
Azoospermia
GR/GR deletions within the azoospermia factor c region on the Y chromosome might not be associated with spermatogenic failure.
Azoospermia
gr/gr-DAZ2-DAZ4-CDY1b deletion is a high-risk factor for male infertility in Tunisian population.
Azoospermia
High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia.
Azoospermia
Identification and characterization of human VCY2-interacting protein: VCY2IP-1, a microtubule-associated protein-like protein.
Azoospermia
Impact of Y chromosome AZFc subdeletion shows lower risk of fertility impairment in Siddi tribal men, Western Ghats, India.
Azoospermia
Inhibin B: a marker for the functional state of the seminiferous epithelium in patients with azoospermia factor C microdeletions.
Azoospermia
Microdeletions of a Y-specific marker, Yfm1, and implications for a role in spermatogenesis.
Azoospermia
MicroRNA expression profiles in testicular biopsies of patients with impaired spermatogenesis.
Azoospermia
Partial AZFc duplications not deletions are associated with male infertility in the Yi population of Yunnan Province, China.
Azoospermia
Partial duplication at AZFc on the Y chromosome is a risk factor for impaired spermatogenesis in Han Chinese in Taiwan.
Azoospermia
Poor intracytoplasmic sperm injection outcome in infertile males with azoospermia factor c microdeletions.
Azoospermia
Prediction model for obtaining spermatozoa with testicular sperm extraction in men with non-obstructive azoospermia.
Azoospermia
Prevalence of chromosomal abnormalities and Y chromosome microdeletion among men with severe semen abnormalities and its correlation with successful sperm retrieval.
Azoospermia
Reproductive outcomes of intracytoplasmic sperm injection using testicular sperm and ejaculated sperm in patients with AZFc microdeletions: a systematic review and meta-analysis.
Azoospermia
Sequence Read Depth Analysis of a Monophyletic Cluster of Y Chromosomes Characterized by Structural Rearrangements in the AZFc Region Resulting in DYS448 Deletion and DYF387S1 Duplication.
Azoospermia
Specific expression of VCY2 in human male germ cells and its involvement in the pathogenesis of male infertility.
Azoospermia
Sperm retrieval from a male with the rare 47, XXYqs variant of Klinefelter syndrome for intracytoplasmic sperm injection: A case report.
Azoospermia
Sperm retrieval rate and reproductive outcome of infertile men with azoospermia factor c deletion.
Azoospermia
Sperm retrieval rates and clinical outcomes for patients with different causes of azoospermia who undergo microdissection testicular sperm extraction-intracytoplasmic sperm injection.
Azoospermia
The Association of Partial Azoospermia Factor C Deletions and Male Infertility in Northwestern China.
Azoospermia
The Low Prevalence of Y Chromosomal Microdeletions is Observed in the Oligozoospermic Men in the Area of Mato Grosso State and Amazonian Region of Brazilian Patients.
Azoospermia
The reproductive outcome of an infertile man with AZFc microdeletions, via intracytoplasmic sperm injection in a high-risk pregnancy: Case report and literature review.
Azoospermia
Useful marker for the estimation of a recombination pair in the partial azoospermia factor c (gr/gr) deletion using quantitative real-time polymerase chain reaction.
Azoospermia
Y chromosome microdeletion and cytogenetic findings in male infertility: A cross-sectional descriptive study.
Azoospermia
Y-chromosomal microdeletions and partial deletions of the Azoospermia Factor c (AZFc) region in normozoospermic, severe oligozoospermic and azoospermic men in Sri Lanka.
Azoospermia
Y-chromosome haplogroup architecture confers susceptibility to azoospermia factor c microrearrangements: a retrospective study.
Azoospermia
Y-chromosome haplogroups and susceptibility to azoospermia factor c microdeletion in an Italian population.
Azoospermia
[Breakpoints located by sequence tagged sites of AZFc microdeletion in Chinese Han population].
Breast Neoplasms
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma.
Breast Neoplasms
Differential stimulation of VEGF-C production by adhesion/growth-regulatory galectins and plant lectins in human breast cancer cells.
Breast Neoplasms
Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor ? in women undergoing anesthesia and surgery for breast cancer.
Breast Neoplasms
Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer--10 years follow-up analysis.
Breast Neoplasms
High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer.
Breast Neoplasms
Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients.
Breast Neoplasms
Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.
Breast Neoplasms
Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Breast Neoplasms
PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer.
Breast Neoplasms
Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
Breast Neoplasms
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
Breast Neoplasms
Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.
Breast Neoplasms
RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer in vitro and in vivo.
Breast Neoplasms
Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors.
Breast Neoplasms
The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer.
Breast Neoplasms
Ultrasound-mediated vascular endothelial growth factor C (VEGF-C) gene microbubble transfection inhibits growth of MCF-7 breast cancer cells.
Breast Neoplasms
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
Breast Neoplasms
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.
Breast Neoplasms
[Expression of vascular endothelial growth factor C in human breast cancer cell lines MCF-7 and MCF-7/Adr]
Breast Neoplasms
[Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer]
Breast Neoplasms
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Breast Neoplasms
[Role of short haipin RNA targeting vascular endothelial growth factor-C on biological characteristics of human breast cancer cell MCF-7]
Breast Neoplasms
[The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer]
Bronchiolitis
Critical Role of VEGF-C/VEGFR-3 Signaling in Innate and Adaptive Immune Responses in Experimental Obliterative Bronchiolitis.
Carcinogenesis
Steroid receptor coactivator-1 interacts with NF-?B to increase VEGFC levels in human thyroid cancer.
Carcinogenesis
[Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
Carcinoma
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.
Carcinoma
Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
Carcinoma
Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
Carcinoma
Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Carcinoma
Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma.
Carcinoma
Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.
Carcinoma
Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Carcinoma
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Carcinoma
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Carcinoma
Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Carcinoma
Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells.
Carcinoma
Expression and significance of vascular endothelial growth factor C from multiple specimen sources in esophageal squamous cell carcinoma.
Carcinoma
Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis.
Carcinoma
Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma.
Carcinoma
Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas.
Carcinoma
Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma.
Carcinoma
Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis.
Carcinoma
Immunoexpression of VEGFR-3, but not the immunoexpression of VEGF-C or lymphatic density, is correlated with metastasis in lower lip squamous cell carcinoma.
Carcinoma
Immunohistochemical expression of PDGFR, VEGF-C, and proteins of the mToR pathway before and after androgen deprivation therapy in prostate carcinoma: significant decrease after treatment.
Carcinoma
Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Carcinoma
Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells.
Carcinoma
Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck.
Carcinoma
Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
Carcinoma
Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma.
Carcinoma
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Carcinoma
prognostic significance of vascular endothelial growth factor C in systemic malignancies besides non-small cell lung carcinomas.
Carcinoma
Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Carcinoma
Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Carcinoma
The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.
Carcinoma
The impact of cyclooxygenase-2 and vascular endothelial growth factor C immunoexpression on the prognosis of penile carcinoma.
Carcinoma
The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Carcinoma
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
Carcinoma
Vascular endothelial growth factor C and microvessel density in gastric carcinoma: correlation with clinicopathological factors. Our experience and review of the literature.
Carcinoma
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Carcinoma
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Carcinoma
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Carcinoma
Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.
Carcinoma
Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
Carcinoma
Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms.
Carcinoma
[Effect of interferon-gamma on the expression of vascular endothelial growth factor C on Hep-2 laryngeal carcinoma cell lines]
Carcinoma
[Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
Carcinoma
[Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]
Carcinoma
[Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance.]
Carcinoma
[Expression of vascular endothelial growth factor C and survivin in gastric carcinoma and their clinical implications]
Carcinoma
[Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma]
Carcinoma
[Expression of VEGF and VEGF-C in laryngeal carcinoma and their clinical significance]
Carcinoma
[Expression related to vascular endothelial growth factor C and induced nitride oxide synthesizase in lymph node micrometastasis of oral squamous cell carcinoma]
Carcinoma
[Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma.]
Carcinoma
[Interaction of vascular endothelial growth factor-C over-expression with tongue squamous cell carcinoma cell line Tca8113 with peri-carcinoma lymphatics]
Carcinoma
[Relationships of human laryngeal squamous cell carcinomas with the expression of VEGF-C and VEGFR-3]
Carcinoma, Hepatocellular
Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
Carcinoma, Hepatocellular
MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma.
Carcinoma, Hepatocellular
Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: Evidence for stromal induction of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Role of VEGF-C Gene Polymorphisms in Susceptibility to Hepatocellular Carcinoma and Its Pathological Development.
Carcinoma, Non-Small-Cell Lung
Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Decreased maspin combined with elevated vascular endothelial growth factor C is associated with poor prognosis in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages.
Carcinoma, Non-Small-Cell Lung
Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Carcinoma, Non-Small-Cell Lung
The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Vascular Endothelial Growth Factor C as a Predictor of Early Recurrence and Poor Prognosis of Resected Stage I Non-small Cell Lung Cancer.
Carcinoma, Non-Small-Cell Lung
[Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
Carcinoma, Non-Small-Cell Lung
[Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]
Carcinoma, Non-Small-Cell Lung
[Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer]
Carcinoma, Non-Small-Cell Lung
[Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance.]
Carcinoma, Non-Small-Cell Lung
[Expression of vascular endothelial growth factor C and its receptor VEGF-R3 and their significance in non-small cell lung cancer.]
Carcinoma, Non-Small-Cell Lung
[Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma.]
Carcinoma, Ovarian Epithelial
Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
Carcinoma, Ovarian Epithelial
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue.
Carcinoma, Renal Cell
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.
Carcinoma, Renal Cell
Expression of 4E-BP1 and phospho-4E-BP1 correlates with the prognosis of patients with clear cell renal carcinoma.
Carcinoma, Renal Cell
Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis.
Carcinoma, Renal Cell
The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Carcinoma, Squamous Cell
Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Carcinoma, Squamous Cell
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Carcinoma, Squamous Cell
Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Carcinoma, Squamous Cell
Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
Carcinoma, Squamous Cell
Immunoexpression of VEGFR-3, but not the immunoexpression of VEGF-C or lymphatic density, is correlated with metastasis in lower lip squamous cell carcinoma.
Carcinoma, Squamous Cell
Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck.
Carcinoma, Squamous Cell
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Carcinoma, Squamous Cell
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Carcinoma, Squamous Cell
[Expression of vascular endothelial growth factor C in laryngeal squamous carcinoma and its role in lymphatic metastasis]
Carcinoma, Squamous Cell
[Expression of VEGF-C and VEGFR-3 in human laryngeal squamous cell carcinomas and cervical metastatic lymph node tissues]
Carcinoma, Squamous Cell
[Interaction of vascular endothelial growth factor-C over-expression with tongue squamous cell carcinoma cell line Tca8113 with peri-carcinoma lymphatics]
Cholangiocarcinoma
Effect of vascular endothelial growth factor-C expression on lymph node metastasis in human cholangiocarcinoma.
Cholangiocarcinoma
Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages.
Colonic Neoplasms
Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer.
Colonic Neoplasms
High-mobility group box 1 protein activating nuclear factor-?B to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
Colonic Neoplasms
Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis.
Colorectal Neoplasms
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Colorectal Neoplasms
Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.
Colorectal Neoplasms
Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Colorectal Neoplasms
Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer.
Colorectal Neoplasms
Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma.
Colorectal Neoplasms
miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.
Colorectal Neoplasms
Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.
Colorectal Neoplasms
Vascular Endothelial Growth Factor C Disrupts the Endothelial Lymphatic Barrier to Promote Colorectal Cancer Invasion.
Colorectal Neoplasms
[The expression of vascular endothelial growth factor C, ETS-1, microvessal density, and microlymphaticdensity and their clinicopathologic in colorectal carcinoma]
Communicable Diseases
Role of Hyperplasia of Gingival Lymphatics in Periodontal Inflammation.
Deafness
A novel frameshift variant of COCH supports the hypothesis that haploinsufficiency is not a cause of autosomal dominant nonsyndromic deafness 9.
Dengue
Spontaneous central vein thrombosis in a patient with activated protein C resistance and dengue infection: An association or causation?
Diabetic Retinopathy
Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.
Dry Eye Syndromes
Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.
Endometriosis
Dysregulation of Vascular Endothelial Growth Factors and Their Neuropilin Receptors in the Eutopic Endometrium of Women With Endometriosis.
Endometriosis
Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.
Endometriosis
Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis.
Endometriosis
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.
Erythema
Non-invasive detection of local tissue responses to predict pressure ulcer development in mouse models.
Esophageal Neoplasms
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Esophageal Neoplasms
Expression of Stathmin and vascular endothelial growth factor C in esophageal cancer and their combined diagnostic value.
Esophageal Neoplasms
Expression of vascular endothelial growth factor C is a prognostic indicator in esophageal cancer.
Esophageal Neoplasms
Mucin 1 and Vascular Endothelial Growth Factor C Expression Correlates with Lymph Node Metastatic Recurrence in Patients with N0 Esophageal Cancer After Ivor-Lewis Esophagectomy.
Esophageal Neoplasms
Overexpression of VEGF-C correlates with a poor prognosis in esophageal cancer patients.
Esophageal Neoplasms
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.
Esophageal Squamous Cell Carcinoma
Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
Esophageal Squamous Cell Carcinoma
Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Esophageal Squamous Cell Carcinoma
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Esophageal Squamous Cell Carcinoma
Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells.
Esophageal Squamous Cell Carcinoma
Expression and significance of vascular endothelial growth factor C from multiple specimen sources in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Esophageal Squamous Cell Carcinoma
The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.
Gastrointestinal Neoplasms
Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial.
Glioblastoma
Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Hearing Loss
Identification of pathogenic mechanisms of COCH mutations, abolished cochlin secretion, and intracellular aggregate formation: genotype-phenotype correlations in DFNA9 deafness and vestibular disorder.
Hearing Loss
[Mutation screening of the COCH gene in familial and sporadic patients with late onset nonsyndromic sensorineural hearing loss among Chinese population]
Hearing Loss, Sensorineural
A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.
Hearing Loss, Sensorineural
Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.
Hearing Loss, Sensorineural
Massively Parallel Sequencing of a Chinese Family with DFNA9 Identified a Novel Missense Mutation in the LCCL Domain of COCH.
Hepatitis B
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer.
Hodgkin Disease
Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.
Hypertension
Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.
Hypertension
Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats.
Infections
Cleaved Cochlin Sequesters Pseudomonas aeruginosa and Activates Innate Immunity in the Inner Ear.
Infections
Evidence for the ancient origin of the NF-{kappa}B/I{kappa}B cascade: Its archaic role in pathogen infection and immunity.
Infertility
Detection of Partial Deletions of Y-chromosome AZFc in Infertile Men Using the Multiplex Ligation-dependent Probe Amplification Assay.
Infertility, Male
Study of AZFc partial deletion gr/gr in fertile and infertile Japanese males.
Infertility, Male
The Association of Partial Azoospermia Factor C Deletions and Male Infertility in Northwestern China.
Infertility, Male
Useful marker for the estimation of a recombination pair in the partial azoospermia factor c (gr/gr) deletion using quantitative real-time polymerase chain reaction.
Infertility, Male
[Study on the relationship between partial deletions in the azzospermia factor C region of Y chromosome and male infertility]
Leiomyoma
Effect of anesthetic technique on serum vascular endothelial growth factor C and prostaglandin E2 levels in women undergoing surgery for uterine leiomyomas.
Leiomyoma
Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth.
Leukemia
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
Leukemia
Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
limulus clotting factor c deficiency
Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt.
limulus clotting factor c deficiency
Platelet-derived growth factor C deficiency in C57BL/6 mice leads to abnormal cerebral vascularization, loss of neuroependymal integrity, and ventricular abnormalities.
Liver Cirrhosis
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.
Liver Neoplasms
Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China.
Lung Neoplasms
Amplified LncRNA PVT1 promotes lung cancer proliferation and metastasis by facilitating VEGFC expression.
Lung Neoplasms
Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
Lung Neoplasms
Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients.
Lung Neoplasms
Decreased maspin combined with elevated vascular endothelial growth factor C is associated with poor prognosis in non-small cell lung cancer.
Lung Neoplasms
Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages.
Lung Neoplasms
Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Lung Neoplasms
Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy.
Lung Neoplasms
Serum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinoma.
Lung Neoplasms
The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer.
Lung Neoplasms
Vascular Endothelial Growth Factor C as a Predictor of Early Recurrence and Poor Prognosis of Resected Stage I Non-small Cell Lung Cancer.
Lung Neoplasms
Vascular endothelial growth factor C complements the ability of positron emission tomography to predict nodal disease in lung cancer.
Lung Neoplasms
Vascular endothelial growth factor C: the predicator of early recurrence in patients with N2 non-small-cell lung cancer.
Lung Neoplasms
[Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
Lung Neoplasms
[Effects on lymphangiogenesis and angiogenesis of lung cancer with antisense oligonucleotides of vascular endothelial growth factor C]
Lung Neoplasms
[Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer]
Lung Neoplasms
[Expression of vascular endothelial growth factor C and its receptor VEGF-R3 and their significance in non-small cell lung cancer.]
Lung Neoplasms
[Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer]
Lymphatic Metastasis
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
Lymphatic Metastasis
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Lymphatic Metastasis
Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
Lymphatic Metastasis
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Lymphatic Metastasis
circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGF?R1/VEGF-D signaling.
Lymphatic Metastasis
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma.
Lymphatic Metastasis
Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.
Lymphatic Metastasis
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Lymphatic Metastasis
Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells.
Lymphatic Metastasis
Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma.
Lymphatic Metastasis
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Lymphatic Metastasis
Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis.
Lymphatic Metastasis
Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma.
Lymphatic Metastasis
Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma.
Lymphatic Metastasis
Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
Lymphatic Metastasis
Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma?
Lymphatic Metastasis
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Lymphatic Metastasis
Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Lymphatic Metastasis
Lymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma Models.
Lymphatic Metastasis
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Lymphatic Metastasis
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.
Lymphatic Metastasis
Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Lymphatic Metastasis
Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
Lymphatic Metastasis
Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
Lymphatic Metastasis
Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Lymphatic Metastasis
PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer.
Lymphatic Metastasis
Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.
Lymphatic Metastasis
Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Lymphatic Metastasis
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Lymphatic Metastasis
Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
Lymphatic Metastasis
Steroid receptor coactivator-1 interacts with NF-?B to increase VEGFC levels in human thyroid cancer.
Lymphatic Metastasis
Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
Lymphatic Metastasis
The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer.
Lymphatic Metastasis
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
Lymphatic Metastasis
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
Lymphatic Metastasis
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Lymphatic Metastasis
Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.
Lymphatic Metastasis
Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (?35 Years).
Lymphatic Metastasis
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.
Lymphatic Metastasis
Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor.
Lymphatic Metastasis
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Lymphatic Metastasis
Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.
Lymphatic Metastasis
Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
Lymphatic Metastasis
Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
Lymphatic Metastasis
Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms.
Lymphatic Metastasis
VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer.
Lymphatic Metastasis
VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.
Lymphatic Metastasis
VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis.
Lymphatic Metastasis
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
Lymphatic Metastasis
[Correlation between the vascular endothelial growth factor C expression and lymph node metastasis in human nasopharyngeal carcinoma]
Lymphatic Metastasis
[Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
Lymphatic Metastasis
[Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]
Lymphatic Metastasis
[Expression of vascular endothelial growth factor C in laryngeal squamous carcinoma and its role in lymphatic metastasis]
Lymphatic Metastasis
[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]
Lymphatic Metastasis
[Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma]
Lymphatic Metastasis
[Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer]
Lymphatic Metastasis
[Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor]
Lymphatic Metastasis
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Lymphatic Metastasis
[Study on relationship between VEGF-C and lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.]
Lymphatic Metastasis
[The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer]
Lymphedema
Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema.
Lymphedema
Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema.
Lymphedema
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema.
Melanoma
Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
Melanoma
Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness.
Melanoma
Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.
Melanoma
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
Melanoma
Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Mumps
Sperm retrieval rates and clinical outcomes for patients with different causes of azoospermia who undergo microdissection testicular sperm extraction-intracytoplasmic sperm injection.
Mycosis Fungoides
Podoplanin Expression Correlates with Disease Progression in Mycosis Fungoides.
Nasopharyngeal Carcinoma
Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
Nasopharyngeal Carcinoma
[Correlation between the vascular endothelial growth factor C expression and lymph node metastasis in human nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Expression and relationship of EBV LMP1, COX-2 and VEGF-C in nasopharyngeal carcinoma]
Neoplasm Metastasis
Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice.
Neoplasm Metastasis
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
Neoplasm Metastasis
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Neoplasm Metastasis
Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
Neoplasm Metastasis
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Neoplasm Metastasis
Chitin hydrolysate stimulates VEGF-C synthesis by MDA-MB-231 breast cancer cells.
Neoplasm Metastasis
Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.
Neoplasm Metastasis
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Neoplasm Metastasis
Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor ? in women undergoing anesthesia and surgery for breast cancer.
Neoplasm Metastasis
Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer.
Neoplasm Metastasis
Effect of vascular endothelial growth factor-C expression on lymph node metastasis in human cholangiocarcinoma.
Neoplasm Metastasis
Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells.
Neoplasm Metastasis
Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma.
Neoplasm Metastasis
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Neoplasm Metastasis
Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis.
Neoplasm Metastasis
Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma.
Neoplasm Metastasis
Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
Neoplasm Metastasis
Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma?
Neoplasm Metastasis
Hedyotis diffusa Willd. inhibits VEGF?C?mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
Neoplasm Metastasis
Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.
Neoplasm Metastasis
High-mobility group box 1 protein activating nuclear factor-?B to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
Neoplasm Metastasis
Identification of a prognostic 28-gene expression signature for gastric cancer with lymphatic metastasis.
Neoplasm Metastasis
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Neoplasm Metastasis
Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Neoplasm Metastasis
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Neoplasm Metastasis
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.
Neoplasm Metastasis
Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Neoplasm Metastasis
M2-Polarized Tumor-Associated Macrophage Infiltration of Regional Lymph Nodes Is Associated With Nodal Lymphangiogenesis and Occult Nodal Involvement in pN0 Pancreatic Cancer.
Neoplasm Metastasis
MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.
Neoplasm Metastasis
Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma.
Neoplasm Metastasis
Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages.
Neoplasm Metastasis
Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
Neoplasm Metastasis
Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Neoplasm Metastasis
Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.
Neoplasm Metastasis
Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Neoplasm Metastasis
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Neoplasm Metastasis
Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
Neoplasm Metastasis
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
Neoplasm Metastasis
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
Neoplasm Metastasis
Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
Neoplasm Metastasis
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
Neoplasm Metastasis
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
Neoplasm Metastasis
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Neoplasm Metastasis
Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.
Neoplasm Metastasis
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
Neoplasm Metastasis
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread.
Neoplasm Metastasis
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
Neoplasm Metastasis
Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer.
Neoplasm Metastasis
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.
Neoplasm Metastasis
Vascular Endothelial Growth Factor C Disrupts the Endothelial Lymphatic Barrier to Promote Colorectal Cancer Invasion.
Neoplasm Metastasis
Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein.
Neoplasm Metastasis
Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
Neoplasm Metastasis
Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor.
Neoplasm Metastasis
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Neoplasm Metastasis
Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.
Neoplasm Metastasis
Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
Neoplasm Metastasis
Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
Neoplasm Metastasis
Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
Neoplasm Metastasis
Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
Neoplasm Metastasis
VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer.
Neoplasm Metastasis
VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.
Neoplasm Metastasis
VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis.
Neoplasm Metastasis
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
Neoplasm Metastasis
[Correlation between the vascular endothelial growth factor C expression and lymph node metastasis in human nasopharyngeal carcinoma]
Neoplasm Metastasis
[Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
Neoplasm Metastasis
[Expression of vascular endothelial growth factor C in laryngeal squamous carcinoma and its role in lymphatic metastasis]
Neoplasm Metastasis
[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]
Neoplasm Metastasis
[Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer]
Neoplasm Metastasis
[Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor]
Neoplasm Metastasis
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Neoplasm Metastasis
[Study on relationship between VEGF-C and lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.]
Neoplasm Micrometastasis
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Neoplasm Micrometastasis
Prognostic significance of VEGF-C in predicting micrometastasis and isolated tumour cells in N0 oral squamous cell carcinoma.
Neoplasm Micrometastasis
[Expression related to vascular endothelial growth factor C and induced nitride oxide synthesizase in lymph node micrometastasis of oral squamous cell carcinoma]
Neoplasms
An origami paper-based nanoformulated immunosensor detects picograms of VEGF-C per milliliter of blood.
Neoplasms
Analyses of VEGFC/VEGF-D expressions, density and endothelial lymphatic proliferation in salivary gland neoplasms.
Neoplasms
Angiogenesis and lymphangiogenesis as prognostic factors after therapy in patients with cervical cancer.
Neoplasms
Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice.
Neoplasms
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
Neoplasms
BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Neoplasms
Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
Neoplasms
Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.
Neoplasms
CCR7-expressing B16 melanoma cells downregulate interferon-?-mediated inflammation and increase lymphangiogenesis in the tumor microenvironment.
Neoplasms
Chitin hydrolysate stimulates VEGF-C synthesis by MDA-MB-231 breast cancer cells.
Neoplasms
Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients.
Neoplasms
Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients.
Neoplasms
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma.
Neoplasms
Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
Neoplasms
Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis.
Neoplasms
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Neoplasms
Correlation of intratumoral lymphatic microvessel density, vascular endothelial growth factor C and cell proliferation in salivary gland tumors.
Neoplasms
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Neoplasms
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model.
Neoplasms
Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.
Neoplasms
Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells.
Neoplasms
Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
Neoplasms
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Neoplasms
Hedyotis diffusa Willd. inhibits VEGF?C?mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
Neoplasms
Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.
Neoplasms
Inhibition of angiogenesis by a novel neutralizing antibody targeting human VEGFR-3.
Neoplasms
Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
Neoplasms
Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer.
Neoplasms
Intratumoral lymphangiogenesis and prognostic significance of VEGFC expression in gastric cancer.
Neoplasms
Lymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma Models.
Neoplasms
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Neoplasms
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas.
Neoplasms
Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells.
Neoplasms
Metastasis associated protein 1 correlates with Hypoxia inducible-factor 1 alpha expression and lymphangiogenesis in esophageal cancer.
Neoplasms
MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Neoplasms
miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.
Neoplasms
Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck.
Neoplasms
Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.
Neoplasms
Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
Neoplasms
Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer.
Neoplasms
Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.
Neoplasms
PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.
Neoplasms
Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
Neoplasms
prognostic significance of vascular endothelial growth factor C in systemic malignancies besides non-small cell lung carcinomas.
Neoplasms
Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
Neoplasms
Prognostic significance of VEGF-C in predicting micrometastasis and isolated tumour cells in N0 oral squamous cell carcinoma.
Neoplasms
Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
Neoplasms
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Neoplasms
Role of VEGF-C Gene Polymorphisms in Susceptibility to Hepatocellular Carcinoma and Its Pathological Development.
Neoplasms
Roquin2 suppresses breast cancer progression by inhibiting tumor angiogenesis via selectively destabilizing proangiogenic factors mRNA.
Neoplasms
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Neoplasms
Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
Neoplasms
Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
Neoplasms
Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.
Neoplasms
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
Neoplasms
The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia.
Neoplasms
The increased number of tumor-associated macrophage is associated with overexpression of VEGF-C, plays an important role in Kazakh ESCC invasion and metastasis.
Neoplasms
The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Neoplasms
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
Neoplasms
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Neoplasms
Tracking tumor cells in lymphatics in a mice xenograft model by magnetic resonance imaging.
Neoplasms
Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway.
Neoplasms
Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.
Neoplasms
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
Neoplasms
Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.
Neoplasms
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
Neoplasms
URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-?B signaling pathway.
Neoplasms
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Neoplasms
Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells.
Neoplasms
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.
Neoplasms
Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms.
Neoplasms
Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
Neoplasms
Vascular endothelial growth factor C-induced lymphangiogenesis decreases tumor interstitial fluid pressure and tumor.
Neoplasms
Vascular endothelial growth factor-C expression as a biomarker of poor prognosis in esophageal squamous cell carcinoma: a meta-analysis.
Neoplasms
Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis.
Neoplasms
Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Neoplasms
VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.
Neoplasms
VEGF-C antisense oligoxydeonucleotide suppression of invasive ability of the A-549 lung carcinoma cell line.
Neoplasms
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
Neoplasms
[Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]
Neoplasms
[Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer]
Neoplasms
[Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor]
Neoplasms
[Study on relationship between VEGF-C and lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.]
Neoplasms
[The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer]
Neoplasms
[VEGF-C and lymphatic vessels: a double-edged sword in tumor development and metastasis].
Neoplasms, Squamous Cell
VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.
Neuroblastoma
Anti-Müllerian hormone signaling is influenced by Follistatin 288, but not 14 other transforming growth factor beta superfamily regulators.
Neuroectodermal Tumors, Primitive
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Oligospermia
Analysis of partial azoospermia factor c deletion and DAZ copy number in azoospermia and severe oligozoospermia.
Oligospermia
MicroRNA expression profiles in testicular biopsies of patients with impaired spermatogenesis.
Orchitis
Sperm retrieval rates and clinical outcomes for patients with different causes of azoospermia who undergo microdissection testicular sperm extraction-intracytoplasmic sperm injection.
Osteoarthritis
Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
Ovarian Neoplasms
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
Pancreatic Neoplasms
Effect of antisense oligodeoxynucleotide of vascular endothelial growth factor C on lymphangiogenesis and angiogenesis of pancreatic cancer.
Pancreatic Neoplasms
Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer.
Pancreatic Neoplasms
Low molecular weight heparin suppresses lymphatic endothelial cell proliferation induced by vascular endothelial growth factor C in vitro.
Pancreatic Neoplasms
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
Pancreatic Neoplasms
VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model.
Pancreatic Neoplasms
[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]
Periodontal Diseases
Lymphangiogenesis is induced during development of periodontal disease.
Peritonitis
Immunohistochemical staining for endotoxin using horseshoe crab factor C in fecal peritonitis.
Polycystic Kidney Diseases
Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases.
Pre-Eclampsia
Allelic variations in angiogenic pathway genes are associated with preeclampsia.
Pre-Eclampsia
CYR61 modulates the vascular endothelial growth factor c expression of decidual NK cells via PI3K/AKT pathway.
Pressure Ulcer
Non-invasive detection of local tissue responses to predict pressure ulcer development in mouse models.
Pressure Ulcer
Prediction of healing in Category I pressure ulcers by skin blotting with plasminogen activator inhibitor 1, interleukin-1?, vascular endothelial growth factor C, and heat shock protein 90?: A pilot study.
Prostatic Hyperplasia
Serum vascular endothelial growth factor C level in patients with prostate cancer and benign prostatic hyperplasia.
Prostatic Hyperplasia
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
Prostatic Neoplasms
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Prostatic Neoplasms
Serum vascular endothelial growth factor C level in patients with prostate cancer and benign prostatic hyperplasia.
Prostatic Neoplasms
Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
Prostatic Neoplasms
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
Protein S Deficiency
Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt.
Pseudomonas Infections
Cleaved Cochlin Sequesters Pseudomonas aeruginosa and Activates Innate Immunity in the Inner Ear.
Rectal Neoplasms
Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
Rectal Neoplasms
[Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
Renal Insufficiency, Chronic
Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects.
Salivary Gland Neoplasms
Analyses of VEGFC/VEGF-D expressions, density and endothelial lymphatic proliferation in salivary gland neoplasms.
Sepsis
The Diagnostic and Prognostic Role of Vascular Endothelial Growth Factor C in Sepsis and Septic Shock.
Sertoli Cell-Only Syndrome
MicroRNA expression profiles in testicular biopsies of patients with impaired spermatogenesis.
Shock, Septic
Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications.
Shock, Septic
The Diagnostic and Prognostic Role of Vascular Endothelial Growth Factor C in Sepsis and Septic Shock.
Small Cell Lung Carcinoma
[Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer]
Squamous Cell Carcinoma of Head and Neck
Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Squamous Cell Carcinoma of Head and Neck
Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells.
Squamous Cell Carcinoma of Head and Neck
[Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma]
Squamous Cell Carcinoma of Head and Neck
[Expression related to vascular endothelial growth factor C and induced nitride oxide synthesizase in lymph node micrometastasis of oral squamous cell carcinoma]
Squamous Cell Carcinoma of Head and Neck
[Relationships of human laryngeal squamous cell carcinomas with the expression of VEGF-C and VEGFR-3]
Stomach Neoplasms
Combined targeting of vascular endothelial growth factor C (VEGFC) and P65 using miR-27b-3p agomir and lipoteichoic acid in the treatment of gastric cancer.
Stomach Neoplasms
Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
Stomach Neoplasms
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients.
Stomach Neoplasms
MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Stomach Neoplasms
Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.
Stomach Neoplasms
Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
Stomach Neoplasms
Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Stomach Neoplasms
[Effects of quercetin on the expression of VEGF-C and VEGFR-3 in human cancer MGC-803 cells.]
Stomach Neoplasms
[Experimental research of the inhibition of vascular endothelial growth factor C expression in gastric cancer by targeting RNA interference]
Stroke
Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial.
Thrombophilia
Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease.
Thrombosis
The localization of lipopolysaccharide in an endotoxemic rat liver and its relation to sinusoidal thrombogenesis: light and electron microscopic studies.
Thyroid Cancer, Papillary
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Thyroid Cancer, Papillary
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Thyroid Cancer, Papillary
[Expression of VEGF-C and angiogenesis, and lymphangiogenesis in papillary thyroid carcinoma]
Tongue Neoplasms
Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer.
Triple Negative Breast Neoplasms
Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells.
Tuberculosis
A Role for Mycobacterium tuberculosis Sigma Factor C in Copper Nutritional Immunity.
Tuberous Sclerosis
Elevated Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Patients with Mesial Temporal Lobe Epilepsy.
Urinary Bladder Neoplasms
circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGF?R1/VEGF-D signaling.
Urinary Bladder Neoplasms
Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer.
Urinary Bladder Neoplasms
MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.
Urinary Bladder Neoplasms
miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells.
Urinary Bladder Neoplasms
VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Uterine Cervical Neoplasms
Angiogenesis and lymphangiogenesis as prognostic factors after therapy in patients with cervical cancer.
Uterine Cervical Neoplasms
Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression.
Uterine Cervical Neoplasms
Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas.
Uterine Cervical Neoplasms
Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B.
Uterine Cervical Neoplasms
Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
Uterine Cervical Neoplasms
Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein.
Uterine Cervical Neoplasms
Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
Uterine Cervical Neoplasms
Vascular endothelial growth factor C expression is closely correlated with lymph node recurrence and poor prognosis in patients with early stage cervical cancer.
Uterine Cervical Neoplasms
Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
Uterine Cervical Neoplasms
Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
Virus Diseases
Andes virus infection of lymphatic endothelial cells causes giant cell and enhanced permeability responses that are rapamycin and vascular endothelial growth factor C sensitive.
html completed